1. Home
  2. Pharma & Healthcare
  3. Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2020 by Company, Type and Application, Forecast to 2025

Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2020 by Company, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 98 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 6615.9 million by 2025, from USD 5125 million in 2019.

The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market has been segmented into PCR, In-situ Hybridization, Immunohistochemistry, Sequencing, Others, etc.

Breakdown by Application, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) has been segmented into Oncology, Neurological Disorders, Cardiovascular Disease, Immunological Disorders, Others, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share Analysis
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) revenue and market share for each player covered in this report.

The major players covered in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) are: Qiagen NV, Pfizer, F Hoffman La Roche, GE Healthcare, Leica Biosystems Nussloch GmBH, Agilent Technologies, Thermo Fisher Scientific Inc., Foundation Medicine, etc. Among other players domestic and global, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Qiagen NV
Pfizer
F Hoffman La Roche
GE Healthcare
Leica Biosystems Nussloch GmBH
Agilent Technologies
Thermo Fisher Scientific Inc.
Foundation Medicine

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

Market segment by Application, can be divided into
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)
1.2 Classification of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) by Type
1.2.1 Overview: Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Type in 2019
1.2.3 PCR
1.2.4 In-situ Hybridization
1.2.5 Immunohistochemistry
1.2.6 Sequencing
1.2.7 Others
1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Application
1.3.1 Overview: Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Oncology
1.3.3 Neurological Disorders
1.3.4 Cardiovascular Disease
1.3.5 Immunological Disorders
1.3.6 Others
1.4 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
1.5 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2015-2020)
1.7 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Status and Prospect (2015-2025)
1.7.2 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Status and Prospect (2015-2025)
1.7.3 Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Status and Prospect (2015-2025)
1.7.4 South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Status and Prospect (2015-2025)

2 Company Profiles
2.1 Qiagen NV
2.1.1 Qiagen NV Details
2.1.2 Qiagen NV Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Qiagen NV SWOT Analysis
2.1.4 Qiagen NV Product and Services
2.1.5 Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.3 F Hoffman La Roche
2.3.1 F Hoffman La Roche Details
2.3.2 F Hoffman La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F Hoffman La Roche SWOT Analysis
2.3.4 F Hoffman La Roche Product and Services
2.3.5 F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GE Healthcare SWOT Analysis
2.4.4 GE Healthcare Product and Services
2.4.5 GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Leica Biosystems Nussloch GmBH
2.5.1 Leica Biosystems Nussloch GmBH Details
2.5.2 Leica Biosystems Nussloch GmBH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Leica Biosystems Nussloch GmBH SWOT Analysis
2.5.4 Leica Biosystems Nussloch GmBH Product and Services
2.5.5 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thermo Fisher Scientific Inc.
2.7.1 Thermo Fisher Scientific Inc. Details
2.7.2 Thermo Fisher Scientific Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Fisher Scientific Inc. SWOT Analysis
2.7.4 Thermo Fisher Scientific Inc. Product and Services
2.7.5 Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Foundation Medicine
2.8.1 Foundation Medicine Details
2.8.2 Foundation Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Foundation Medicine SWOT Analysis
2.8.4 Foundation Medicine Product and Services
2.8.5 Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Players (2015-2020)
3.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players Market Share
3.3.2 Top 10 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Countries (2015-2020)
4.2 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Countries (2015-2026)
4.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
4.4 Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
4.5 Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Countries (2015-2020)
5.2 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Countries (2015-2026)
5.3 Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
5.4 France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
5.5 UK Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
5.6 Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
5.7 Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2015-2020)
6.2 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Regions (2015-2026)
6.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
6.4 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
6.5 Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
6.6 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
6.7 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Countries (2015-2020)
7.2 South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
7.4 Argentina Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Regions (2015-2020)
8.2 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
8.4 UAE Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
8.5 Egypt Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)
8.6 South Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Type (2015-2025)
9.1.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
9.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast by Type (2020-2025)
9.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Type (2015-2025)
9.2.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
9.2.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Application (2015-2025)
10.1.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
10.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast by Application (2020-2025)
10.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Forecast by Application (2015-2025)
10.2.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
10.2.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

Tables and Figures

List of Tables

Table 1. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Regions (2015-2020)
Table 7. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Regions (2020-2025)
Table 9. Qiagen NV Corporate Information, Location and Competitors
Table 10. Qiagen NV Major Business
Table 11. Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 12. Qiagen NV SWOT Analysis
Table 13. Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 14. Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Pfizer Corporate Information, Location and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2018-2019)
Table 18. Pfizer SWOT Analysis
Table 19. Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 20. Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. F Hoffman La Roche Corporate Information, Location and Competitors
Table 22. F Hoffman La Roche Major Business
Table 23. F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 24. F Hoffman La Roche SWOT Analysis
Table 25. F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 26. F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. GE Healthcare Corporate Information, Location and Competitors
Table 28. GE Healthcare Major Business
Table 29. GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 30. GE Healthcare SWOT Analysis
Table 31. GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 32. GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Leica Biosystems Nussloch GmBH Corporate Information, Location and Competitors
Table 34. Leica Biosystems Nussloch GmBH Major Business
Table 35. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 36. Leica Biosystems Nussloch GmBH SWOT Analysis
Table 37. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 38. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Agilent Technologies Corporate Information, Location and Competitors
Table 40. Agilent Technologies Major Business
Table 41. Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 42. Agilent Technologies SWOT Analysis
Table 43. Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 44. Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Thermo Fisher Scientific Inc. Corporate Information, Location and Competitors
Table 46. Thermo Fisher Scientific Inc. Major Business
Table 47. Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 48. Thermo Fisher Scientific Inc. SWOT Analysis
Table 49. Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 50. Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Foundation Medicine Corporate Information, Location and Competitors
Table 52. Foundation Medicine Major Business
Table 53. Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Total Revenue (USD Million) (2017-2018)
Table 54. Foundation Medicine SWOT Analysis
Table 55. Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product and Solutions
Table 56. Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Players (2015-2020)
Table 58. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Players (2015-2020)
Table 59. Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) in China (2015-2020)
Table 60. Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share in China (2015-2020)
Table 61. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2015-2020)
Table 62. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2015-2020)
Table 63. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2020-2026)
Table 64. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2020-2026)
Table 65. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2015-2020)
Table 66. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2015-2020)
Table 67. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2020-2026)
Table 68. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2020-2026)
Table 69. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2015-2020)
Table 70. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2015-2020)
Table 71. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2020-2026)
Table 72. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2020-2026)
Table 73. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2015-2020)
Table 74. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2015-2020)
Table 75. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2020-2026)
Table 76. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2020-2026)
Table 77. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2015-2020)
Table 78. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2015-2020)
Table 79. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Countries (2020-2026)
Table 80. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Countries (2020-2026)
Table 81. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Type (2015-2020)
Table 82. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Type (2015-2020)
Table 83. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Forecast by Type (2020-2025)
Table 84. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share Forecast by Type (2020-2025)
Table 85. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Type (2015-2020)
Table 86. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Type (2015-2020)
Table 87. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Forecast by Type (2020-2025)
Table 88. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share Forecast by Type (2020-2025)
Table 89. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Application (2015-2020)
Table 90. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Application (2015-2020)
Table 91. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Forecast by Application (2020-2025)
Table 92. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share Forecast by Application (2020-2025)
Table 93. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) by Application (2015-2020)
Table 94. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Application (2015-2020)
Table 95. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Forecast by Application (2020-2025)
Table 96. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Picture
Figure 2. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Type in 2019
Figure 4. PCR Picture
Figure 5. In-situ Hybridization Picture
Figure 6. Immunohistochemistry Picture
Figure 7. Sequencing Picture
Figure 8. Others Picture
Figure 9. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Application in 2019
Figure 10. Oncology Picture
Figure 11. Neurological Disorders Picture
Figure 12. Cardiovascular Disease Picture
Figure 13. Immunological Disorders Picture
Figure 14. Others Picture
Figure 15. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2015-2025) (USD Million)
Figure 16. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions (2015-2025)
Figure 17. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions in 2019
Figure 18. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Regions (2020-2025)
Figure 19. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 24. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share in 2019
Figure 26. Top 10 Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share in Global Market in 2019
Figure 27. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) by Type (2015-2025)
Figure 28. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2015-2025)
Figure 29. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries (2015-2025)
Figure 30. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries in 2019
Figure 31. United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 32. Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 33. Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries (2015-2025)
Figure 35. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries in 2019
Figure 36. Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 37. France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 39. Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 40. Spain Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 41. UK Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries (2015-2025)
Figure 43. Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries in 2019
Figure 44. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 46. Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 47. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 49. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries (2015-2025)
Figure 50. South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries in 2019
Figure 51. Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 52. Argentina Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 53. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries (2015-2025)
Figure 54. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Countries in 2019
Figure 55. Saudi Arabia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 56. UAE Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 57. Egypt Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 58. South Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (USD Million) and Forecast (2015-2025)
Figure 59. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Type (2015-2020)
Figure 60. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Type (2015-2020)
Figure 61. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Application (2015-2020)
Figure 62. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Share by Application (2015-2020)




Companies Mentioned
Qiagen NV
Pfizer
F Hoffman La Roche
GE Healthcare
Leica Biosystems Nussloch GmBH
Agilent Technologies
Thermo Fisher Scientific Inc.
Foundation Medicine

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets